Zoetis Inc
NYSE:ZTS
Zoetis Inc
Deferred Income Tax
Zoetis Inc
Deferred Income Tax Peer Comparison
Competitive Deferred Income Tax Analysis
Latest Figures & CAGR of Competitors
Company | Deferred Income Tax | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Zoetis Inc
NYSE:ZTS
|
Deferred Income Tax
$136m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-8%
|
|
Johnson & Johnson
NYSE:JNJ
|
Deferred Income Tax
$3.2B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-4%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Deferred Income Tax
$442m
|
CAGR 3-Years
-56%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
19%
|
|
Pfizer Inc
NYSE:PFE
|
Deferred Income Tax
$931m
|
CAGR 3-Years
-40%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
-28%
|
|
Merck & Co Inc
NYSE:MRK
|
Deferred Income Tax
$922m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-17%
|
|
Eli Lilly and Co
NYSE:LLY
|
Deferred Income Tax
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Zoetis Inc's Deferred Income Tax?
Deferred Income Tax
136m
USD
Based on the financial report for Mar 31, 2024, Zoetis Inc's Deferred Income Tax amounts to 136m USD.
What is Zoetis Inc's Deferred Income Tax growth rate?
Deferred Income Tax CAGR 10Y
-8%
Over the last year, the Deferred Income Tax growth was 4%. The average annual Deferred Income Tax growth rates for Zoetis Inc have been -30% over the past three years , -22% over the past five years , and -8% over the past ten years .